ARNX--more on the Conference at which they are presenting Sunday:
<<A great way for biotech investors to make potentially quick gains is to watch the scientific conference schedule and figure out which companies will be spotlighted. This is a great forum for biotechs to strut their stuff in front of analysts and institutions that may not have previously known anything about the company. The bigger the conference is, the better the national exposure. Stocks sometimes move higher with positive data on products, and occasionally tank on better news from a competitor, even if the company presents positive results itself.
The Interscience Conference on Antimicrobial Agents and Chemotherapy is a conference that focuses on infectious diseases, and is scheduled Sept. 26-29 in San Francisco. ICAAC has become one of the major scientific forums for presentations on pipeline products for HIV and AIDS. This year's conference will include data from products that treat diseases such as influenza (the flu) and the common cold.
The best forum to display positive results is the "late-breaking" sessions. The conference room during these sessions is packed liked a can of sardines, with mutual fund managers and physicians standing side by side awaiting a company's announcement that it has a cure for AIDS. It's been said that more than five times as many studies are submitted as are eventually accepted. How do you find out about the late-breaker sessions? Call companies directly, fastidiously check out the conference Web site and read analyst reports - there are numerous ways. >>
Source: ragingbull.com
<<Anthony H. Williams, M.D., Vice President Medical Affairs, Aronex Pharmaceuticals, will present data from the completed Phase III clinical trial, which evaluated NYOTRAN in 538 patients with presumed fungal infections who had failed 72 hours of previous antibacterial therapy. The data will be presented on Sunday, September 26, 1999, at 12:24 p.m. in Late Breaker Session Number 29 in Room 103/104.
Five separate posters or presentations on NYOTRAN will be presented during the ICAAC conference from September 26-29, 1999. A schedule of the presentations and posters is listed below, and copies of the abstracts may be obtained from the ICAAC website at www.asmusa.org, or by contacting Aronex Pharmaceuticals' Corporate Communications Department.>>
|
